1
|
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
|
J Exp Med
|
2010
|
2.23
|
2
|
Genomics of human intracranial aneurysm wall.
|
Stroke
|
2009
|
2.06
|
3
|
Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease.
|
Stroke
|
2011
|
1.91
|
4
|
Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion.
|
Stroke
|
2005
|
1.70
|
5
|
A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.
|
Hum Mol Genet
|
2010
|
1.39
|
6
|
Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance.
|
Neurosurgery
|
2004
|
1.29
|
7
|
Cerebral cavernous malformations: somatic mutations in vascular endothelial cells.
|
Neurosurgery
|
2009
|
1.10
|
8
|
Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation.
|
J Neurosurg
|
2007
|
1.01
|
9
|
Immune response in human cerebral cavernous malformations.
|
Stroke
|
2009
|
0.94
|
10
|
Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping.
|
Invest Radiol
|
2014
|
0.91
|
11
|
Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations.
|
Stroke
|
2013
|
0.91
|
12
|
Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution.
|
Neurosurg Focus
|
2010
|
0.91
|
13
|
Cerebral cavernous malformations: clinical insights from genetic studies.
|
Neurosurg Focus
|
2006
|
0.86
|
14
|
On-pump coronary artery bypass surgery activates human myocardial NF-kappaB and increases TNF-alpha in the heart.
|
J Surg Res
|
2003
|
0.81
|
15
|
Corrigendum: Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
|
Nature
|
2016
|
0.79
|
16
|
Lipopolysaccharide-induced neutrophil gene expression under in vivo or in vitro conditions.
|
Chest
|
2002
|
0.78
|